title: Acquired amegakaryocytic thrombocytopenia: potential role of thrombopoietin receptor agonists.
authors.affiliation: Department of Haematology, St George's Hospital, SW17 0QT, London, UK.
authors.forename: Robert
authors.initials: R
authors.lastname: Lown
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Rhodes
authors.forename: Jenny
authors.initials: J
authors.lastname: Bosworth
authors.forename: Muriel S
authors.initials: MS
authors.lastname: Shannon
authors.forename: Roberto
authors.initials: R
authors.lastname: Stasi
mesh_terms: D001565:Benzoates / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000188:drug therapy; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy; D011720:Pyrazoles / Q000627:therapeutic use; D011961:Receptors, Fc / Q000627:therapeutic use; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D016879:Salvage Therapy / Q000379:methods; D013926:Thrombopoietin / Q000627:therapeutic use
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim; C520809:eltrombopag